Proclaiming itself the "pioneer" in generative artificial intelligence (AI), Cerebras and its stock have drawn increasing attention from AI investors, engineers, and aficionados. In March 2024, Cerebras introduced the Third Generation 5nm Wafer Scale Engine, or WSE-3, which the company claims is the fastest AI chip. It's no wonder Cerebras is garnering considerable interest from the AI community.
With Open AI's launch of ChatGPT in late 2022, generative AI exploded onto the scene. Now, it and other generative AI models are becoming increasingly present in our daily lives. It's hardly expected to slow down. According to Bloomberg Intelligence, the generative AI market is projected to grow from about $40 billion in 2022 to more than $1.3 trillion in 2032 -- a compound annual growth rate (CAGR) of almost 42%.
In addition to several government laboratories, Cerebras has a variety of customers operating in the private sector. The Mayo Clinic, for example, has turned to Cerebras for assistance in developing AI models for healthcare.
Financial details of the relationship are scarce, but Cerebras CEO Andrew Feldman identified the deal as a "multimillion-dollar" arrangement. Oil supermajor TotalEnergies (TTE +3.19%) has also enlisted Cerebras to help with seismic modeling.
While investors may be motivated to add Cerebras to their portfolios, there are important things to consider. Besides looking at how to buy shares of Cerebras stock, investors will want to consider when the company plans to hold its initial public offering (IPO) and whether alternative investment opportunities exist.
Artificial Intelligence
Is Cerebras publicly traded?
As of late 2025, Cerebras was not a publicly traded company; however, earlier in 2024, the company had submitted SEC Form S-1 indicating its plan to IPO in the near future.
Cerebras has held several funding rounds that have helped it to raise capital from investors like the Abu Dhabi Growth Fund and venture firm Benchmark Capital. After completing a Series F round in 2021, Cerebras had raised about $715 million in funding, according to Crunchbase.
In August 2025, it was revealed that the company is considering a private funding round to raise up to $1 billion, which would further delay a potential IPO.
IPO
When will Cerebras IPO?
While Cerebras is not officially on the calendar to hold an IPO, the company has discussed that going public is the plan. In May 2025, Feldman said "That's our aspiration," in regards to taking the company public before the end of the year.
In its Form S-1, Cerebras stated that it had chosen Citigroup (C -1.72%) and Barclays (BCS +0.27%) to act as joint book-running managers for the IPO. There is no indication as to the listing date for Cerebras stock, but the company plans to trade on the Nasdaq exchange under the stock ticker CBRS. So, investors may soon have the opportunity to buy this IPO stock. Consistent with its latest funding round in 2021, Cerebras may seek a valuation in excess of $4 billion.
Is Cerebras profitable?
Since Cerbras is privately held, it isn't required to report its financial results publicly. But based on the company's S-1 filing, Cerebras has not achieved profitability. Although the company is profitable on a gross profit basis -- it posted gross profits of $2.9 million and $26.4 million in 2022 and 2023, respectively -- Cerebras reported net losses in each of the previous two years.
While it's not reporting positive earnings, Cerebras deserves recognition for narrowing its losses. Through the first six months of 2024, Cerebras has a net loss of $66.6 million, representing an improvement over the net loss of $77.8 million that it reported during the same period in 2023.
Alternatives to Cerebras stock
For most investors, picking up shares of Cerebras before the IPO is not possible. People who qualify as accredited investors, on the other hand, may be able to buy Cerebras stock before its IPO. Some platforms, like Forge Global (FRGE -0.20%), allow accredited investors to buy shares of pre-IPO companies like Cerebras.
Although people who don't qualify as accredited investors may be unable to buy Cerebras stock, that doesn't mean they're completely out of luck. There are a variety of other AI stocks for them to consider.
1. Nvidia
One of the most obvious alternatives for prospective Cerebras investors is AI stalwart Nvidia (NVDA +1.60%), arguably Cerebras' most formidable competitor. With its Hopper Tensor Core GPU (graphic processing units), Nvidia was already an industry leader in supporting AI computing.
However, Nvidia upped its AI game in March 2024 with its X800 series network switches. The company characterizes the X800 switches as "end-to-end networking platforms that enable us to achieve trillion-parameter-scale generative AI essential for new AI infrastructures."
Despite its commanding position -- the company's market capitalization exceeded $4.45 trillion in December 2025 -- there's still a general consensus among investors that Nvidia has plenty of opportunities for growth ahead of it.
And since it generates massive amounts of cash, it represents an AI investment opportunity at the lower end of the risk spectrum. In fiscal year 2025, for instance, Nvidia reported a free cash flow of $60.7 billion.
Market Capitalization
2. Qualcomm
Instead of a competitor, investors may feel more compelled to pick up shares of a collaborator. Qualcomm (QCOM -1.25%) has partnered with Cerebras, allowing investors to indirectly gain exposure to the privately held company.
In March 2024, Cerebras announced it had selected Qualcomm's Cloud AI 100 Ultra, an AI inference card designed specifically for generative AI and large language models, to be used with its CS-3 AI accelerators for training to provide a superior AI solution.
Simply branding Qualcomm as an AI company would be giving it short shrift. As a leading semiconductor company, Qualcomm provides wireless solutions found in numerous applications, including smartphones, vehicles, and devices operating on the Internet of Things.
The company has a variety of available growth opportunities. While investors wait for these to play out, they can reap the rewards of the company's dividend, which had a forward yield of 2.24% as of September 2025.
3. Astera Labs
Instead of waiting for Cerebras to hold its IPO, investors can opt for an AI-oriented semiconductor stock that recently held its IPO -- a stock like Astera Labs (ALAB -3.79%). The company offers its Intelligent Connectivity Platform to meet the connectivity demands of AI and cloud infrastructures.
Already, the company has secured some industry leaders as customers, including Advanced Micro Devices' (AMD +2.35%), Intel (INTC -17.15%), and Nvidia.
The company posted revenue of $191.9 million in the second quarter of 2025, up 150% year over year.
How to buy stocks similar to Cerebras
Here's a brief guide on how to buy stocks similar to Cerebras.
- Open your brokerage account: Log in to your brokerage account where you handle your investments.
- Search for the stock: Enter the ticker or company name into the search bar to bring up the stock's trading page.
- Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to this stock.
- Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
- Submit your order: Confirm the details and submit your buy order.
- Review your purchase: Check your portfolio to ensure your order was filled as expected and adjust your investment strategy accordingly.
ETFs with exposure to Cerebras
Cerebras isn't publicly traded, so investors can't gain exposure to the company through an exchange-traded fund (ETF). But other options exist. There are several artificial intelligence (AI) ETFs that may interest investors.
- Vanguard Information Technology ETF (VGT +0.10%): Though AI isn't specified in the ETF's name, the fund has plenty of AI exposure. Nvidia is the ETF's largest holding; Broadcom (AVGO -1.61%) and Advanced Micro Devices are the fourth- and seventh-largest holdings, respectively. The ETF has a low expense ratio of 0.09% and makes quarterly distributions.
- Roundhill Generative AI & Technology ETF (CHAT -0.45%): Branding itself the "world's first Generative AI ETF," this ETF may be an ideal option for investors frustrated that they can't buy Cerebras stock. Nvidia is the ETF's largest holding, and OpenAI partner Microsoft (MSFT +3.45%) represents the ETF's fourth-largest position. Combined, Nvidia and Microsoft account for more than 12% of the ETF's portfolio, which has 37 holdings and a 0.75% expense ratio.
- Global X Artificial Intelligence & Technology ETF (AIQ +0.11%): With 94 holdings in its portfolio, this ETF provides a broader approach to AI. In addition to holding companies that produce hardware catering to AI, the ETF aims to invest in "companies that potentially stand to benefit from the further development and utilization of artificial intelligence (AI) technology in their products and services." Besides top holdings Nvidia, Broadcom, and Qualcomm, the ETF includes Meta Platforms (META +1.72%), Netflix (NFLX +3.17%), and Amazon (AMZN +2.12%) in its top holdings, with a 0.68% total expense ratio.
Related investing topics
The bottom line on Cerebras
In light of the massive growth that the generative AI market is expected to experience over the next decade, it's unsurprising that investors have Cerebras on their radar. While the company has achieved noteworthy success, it's unclear how this success has translated to the company's financial health -- something investors will have a better sense of if the company proceeds with its plans to hold an IPO. In the meantime, investors have a variety of other AI stocks and ETFs they can consider.
FAQ
Investing in Cerebras FAQ
About the Author
